Nanobiotix & Beyond
Nanobiotix is a company built by people for people.
That’s why we encourage our team, friends and families to take an active part of patients’ life and society.
Run For Life
Each year, Nanobiotix team, families and friends run the ODYSSEA race in Vincennes to support the fight against breast cancer. For the sixth consecutive year, over 160 “Nanomembers” ran for the cause and committed to help support research in the fight against cancer.
Profits from this race go to Institut Gustave Roussy, the first European cancer research facility to focus on developing cancer treatments.
Nanomedicine Translation Advisory Board
Laurent Levy is one of the high experienced experts involved in the project to provide free of charge advice and support to very ambitious European Nanomedicine projects. The Nanomedicine Translation Advisory Board (TAB) aims to guide and promote innovative selected Nanomedicine projects by helping them to make the right strategic choices at the right time. Thus time to market to propose innovative products for healthcare of the supported projects could be shorten.
The TAB experts are coming from the pharma and healthcare industries, mainly biotech and nanotech entrepreneurs, but also high level professionals with specific competences (IP, business, regulatory, etc.). They all are experts who already went through these challenges.
Sharing our passion with students
We love to share our passion for innovation, nanomedicine and entrepreneurship.
Nanobiotix team is regularly involved in teaching activities or seminars for universities and engineer schools.
Education for the Future
Each year, Nanobiotix is organizing high school students open half-days in its office. These meetings are devoted to educate future generations to the research world and explain what nanomedicine is. Discuss with younger generation is fascinating: their concerns, creativity, ambitions and open minds are always a source of inspiration.
ETPN & Nanomed Alliance
Nanobiotix plays an active role in shaping the nanomedicine industry through multiple associations in Europe and in US.
The European Technology Platform on Nanomedicine: Created in 2005, the ETPN is an initiative led by Industry and set up together with the European Commission to address the applications of nanotechnology to achieve breakthroughs in healthcare. The ETPN is structuring and federating the European Nanomedicine community with the goal to improve patient’s access to innovative nanomedicines.
The Nanomedicines Alliance: The Nanomedicines Alliance focuses on the global advancement of nanomedicines from research to commercialization, with the mission to promote and facilitate the scientific advancement, regulatory approval, and public appreciation of nanotechnology‐based medicines world‐wide for the diagnosis, treatment and prevention of disease.